MCH supplementation has been explored in Alzheimer's disease models, where intracerebroventricular (ICV) administration of MCH (0.5 μg/day for 2 weeks) restored REM sleep and reduced abnormal hippocampal neuronal activity, improving memory retention.113, 227. This evidence concerns the gene PMCH and early-onset autosomal dominant Alzheimer disease.